1 not yet recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow IIM: new trials by email Literature Review of IIM trials Research Report on IIM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1 CAR-T cells targeting CD19 - Pemphigus Vulgaris (PV), ANCA Associated Vasculitis (AAV) | Phase 1 / Phase 2 | Not yet recruiting | University Hospital Tuebingen | 36 | 2027-01-01 | 2026-11-12 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arthritis, Rheumatoid (1) · Multiple Sclerosis (1) · Pemphigus (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Scleroderma, Systemic (1)
Arthritis (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Cardiovascular Diseases (1) · Connective Tissue Diseases (1) · Cytopenia (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhage (1) · Hemorrhagic Disorders (1) · Immune System Diseases (1)
University Hospital Tuebingen (1)
Germany (1)